stabend






The trial team in Akershus randomised two new patients and the trial teams in Lübeck, Osaka, Graz, Alesund, Mannheim and Linz Neurologie 2 randomised one new patient each. Many thanks and congratulations on this great achievement!

Eight new patients randomised!